Moderate to Severe Rheumatoid Arthritis research hub

A study to find how safe different doses of LFD-200 are and how it works in both healthy people and people with moderate to severe rheumatoid arthritis

This study is looking at a new medicine called LFD-200. It's for people with moderate to severe rheumatoid arthritis, as well as healthy volunteers. Doctors want to see how safe different amounts of the medicine are and how it works in the body.

A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis